Skip to main content

IG 302 (Alfuzosin Hydrochloride Extended-Release 10 mg)

Pill with imprint IG 302 is White, Round and has been identified as Alfuzosin Hydrochloride Extended-Release 10 mg. It is supplied by Cipla USA, Inc.

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class alpha-adrenoreceptor antagonists. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG 302

Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302 Front
Alfuzosin hydrochloride extended-release 10 mg IG 302 Back
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302

Alfuzosin Hydrochloride Extended-Release

Imprint
IG 302
Strength
10 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Alpha-adrenoreceptor antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
69097-0844
Inactive Ingredients
microcrystalline cellulose, guar gum, hypromelloses, silicon dioxide, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.